4th Sep 2006 11:53
GlaxoSmithKline PLC04 September 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 31 August 2006 Abacus Corporate Trustees Limited, as trustee of the GlaxoSmithKline (US) Trust, ("the GSK US Trust"), sold 852 Ordinary Share ADRs in the Company on behalf of participants in the GlaxoSmithKline Share Value Plan at a price of $56.80 per ADR. The GSK US Trust transferred 1,644 Ordinary Share ADRs in the Company to participants in the GlaxoSmithKline Share Value Plan. The Company was advised of these transactions on 1 September 2006. The GSK Trust is a discretionary trust of which all employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr M M Slaouiand Mr J S Heslop are therefore interested in the shares held in the GSK Trustfrom time to time in the same way as other employees or former employees ofGlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M BicknellCompany Secretary 4 September 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline